Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 900 studies
Open to sponsorsGeneral clinicalView Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 130 studies
Open to sponsorsGeneral clinicalView Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 400 studies
Open to sponsorsGeneral clinicalView